POLISCOPE
Back to feed
HR3164FEDERALin_committee
Finance Detected

Ensuring Community Access to Pharmacist Services Act (H.R. 3164)

Original title: Ensuring Community Access to Pharmacist Services Act

May 1, 2025

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Where This Stands

Introduced
Committee
Floor Vote
Passed
Signed

Currently in_committee. The next step in the legislative lifecycle is Floor Vote.

Last action
Ordered to be Reported in the Nature of a Substitute by Voice Vote.May 21, 2026

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Finance Connection

Notable money activity
$200across 1 reported contribution
Trace money trail →
CandidateDonorAmountIndustryDate
Schneider for City Council 2020Mohammad Monshizadeh$200Vice PresidentOct 2020

Reported financial relationships and timing signals. This does not prove motive or influence. Readers draw their own conclusions.

The Frame

What this does

Starting January 1, 2026, Medicare beneficiaries could receive coverage for pharmacist-led testing and treatment for illnesses like COVID-19, flu, and strep throat, potentially increasing access to care in local pharmacies.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Medicare beneficiaries

They would gain access to Medicare-covered testing and treatment services provided by pharmacists.

Pharmacists

They would be eligible to receive Medicare reimbursement for specific clinical services provided they meet state law and collaboration requirements.

Physicians

They may be required to enter into collaborative agreements or provide supervision for pharmacists performing these services, depending on state law.

What changed

Current stage: in_committee.

What's next

Floor Vote.

Summary

This bill proposes to allow to pay for specific services provided by pharmacists, such as testing and treatment for common respiratory illnesses and other public health needs. It establishes payment rates for these services and prohibits pharmacists from charging patients more than the Medicare-approved amount.

Why It Matters

Starting January 1, 2026, Medicare beneficiaries could receive coverage for pharmacist-led testing and treatment for illnesses like COVID-19, flu, and strep throat, potentially increasing access to care in local pharmacies.

Key Facts

  • The bill amends Medicare Part B to include coverage for specific pharmacist-provided services.
  • Covered services include evaluation, testing, and treatment for COVID-19, influenza, respiratory syncytial virus (RSV), and streptococcal pharyngitis.
  • Pharmacists may provide services related to public health emergencies as declared by the Secretary of Health and Human Services.
  • Services must be performed within the scope of state law and, where required, under the supervision of or in collaboration with a physician.
  • Medicare payment for these services is set at 80% of the lesser of the actual charge or 85% of the standard physician fee schedule.
  • For public health emergency services, the payment rate is 80% of the lesser of the actual charge or 100% of the standard physician fee schedule.
  • The bill prohibits 'balance billing,' meaning pharmacists cannot charge patients for the difference between their fee and the Medicare-approved amount.
  • The provisions of this act are scheduled to take effect on January 1, 2026.

Frequently Asked Questions

Will Medicare cover my pharmacy visit for a flu test?
If this bill passes, would cover testing and treatment for influenza and other specified respiratory illnesses starting January 1, 2026.
Can a pharmacist charge me extra if Medicare doesn't pay the full amount?
No, the bill includes a prohibition on , which prevents pharmacists from charging Medicare patients for the difference between their fee and the Medicare-approved payment amount.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Sponsors

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift95% confidence

Expansion of Pharmacist Scope

The bill represents a shift toward integrating pharmacists into the primary care reimbursement structure for Medicare, specifically for infectious disease testing.

Connected Entities

personSchneiderCo-sponsor of the bill.Map →
otherSocial Security ActThe primary law being amended by this bill.Map →
personMatsuiCo-sponsor of the bill.Map →
personSmith of NebraskaPrimary sponsor of the bill.Map →
personHarshbargerCo-sponsor of the bill.Map →

Analysis Score

0–100
  • Significance65
    How much this matters to a regular citizen
  • Controversy20
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz30
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record